The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASCO GI 2022 | Key updates at ASCO GI 2022
Afsaneh Barzi, MD, PhD, City of Hope, Duarte, CA, talks on what she is most excited for at the American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium 2022 (ASCO GI 2022). Dr. Barzi is particularly interested in studies on biliary cancer including the Phase III TOPAZ-1 (NCT03875235) trial, the findings of which will be discussed at ASCO GI 2022. This interview took place at the American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium 2022.
